Cargando…
Dual Role of Triptolide in Interrupting the NLRP3 Inflammasome Pathway to Attenuate Cardiac Fibrosis
In a previous paper, we reported that triptolide (TP), a commonly used immunomodulator, could attenuate cardiac hypertrophy. This present study aimed to further explore the inhibition of cardiac fibrosis by TP and the possible mechanism from the perspective of the NOD-like receptor protein 3 (NLRP3)...
Autores principales: | Pan, Xi-Chun, Liu, Ya, Cen, Yan-Yan, Xiong, Ya-Lan, Li, Jing-Mei, Ding, Yuan-Yuan, Tong, Yang-Fei, Liu, Tao, Chen, Xiao-Hong, Zhang, Hai-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359320/ https://www.ncbi.nlm.nih.gov/pubmed/30654511 http://dx.doi.org/10.3390/ijms20020360 |
Ejemplares similares
-
Triptolide Upregulates Myocardial Forkhead Helix Transcription Factor p3 Expression and Attenuates Cardiac Hypertrophy
por: Ding, Yuan-Yuan, et al.
Publicado: (2016) -
Cardiomyocytic FoxP3 is involved in Parkin-mediated mitophagy during cardiac remodeling and the regulatory role of triptolide
por: Pan, Xi-Chun, et al.
Publicado: (2022) -
Effect of Triptolide on Temporal Expression of Cell Cycle Regulators During Cardiac Hypertrophy
por: Li, Jing-Mei, et al.
Publicado: (2020) -
Inhibition of FABP4 attenuates cardiac fibrosis through inhibition of NLRP3 inflammasome activation
por: Zhu, Xi, et al.
Publicado: (2022) -
Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome
por: Seo, Jung Beom, et al.
Publicado: (2019)